-
D. Boral Capital Reiterates "Buy" Rating for UroGen Pharma (NASDAQ:URGN)
ソース: Buzz FX / 19 2 2025 08:16:13 America/New_York
D. Boral Capital Reiterates "Buy" Rating for UroGen Pharma (NASDAQ:URGN) Written by MarketBeat February 19, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by equ
Read more...